Bipolar disorder treatment that starts with getting the diagnosis right.
Bipolar disorder is one of the most frequently misdiagnosed conditions in outpatient psychiatry — in both directions. At Wave Psychiatric Group, our board-certified psychiatrists bring the clinical rigor and longitudinal commitment that accurate diagnosis and effective long-term management of bipolar disorder require.
Understanding bipolar disorder
Bipolar disorder is a complex mood disorder characterized by episodes of depression and mania or hypomania — states of elevated, expansive, or irritable mood, increased energy, decreased need for sleep, and a range of other symptoms that represent a distinct departure from a person's baseline functioning. It is a condition that spans a spectrum of presentations, from the severe manic episodes and profound depressive lows of bipolar I disorder to the more subtle but still significantly impairing hypomanic and depressive cycles of bipolar II disorder and the chronic mood instability of cyclothymia.
Like all psychiatric conditions, bipolar disorder is best understood not as a simple biological malfunction but as the product of a complex interaction between genetic vulnerability, neurobiological dysregulation, psychological factors, and environmental influences. The kindling model — in which early mood episodes sensitize the nervous system to subsequent episodes, lowering the threshold for future cycling — underscores the clinical importance of early, adequate treatment and the risks of leaving the condition undertreated or mismanaged over time.
Bipolar disorder is associated with significant functional impairment across occupational, relational, and health domains, and with elevated rates of suicide — particularly during depressive and mixed episodes. It is also associated with a diagnostic delay that, on average, spans nearly a decade from onset of symptoms to accurate diagnosis. That delay has real consequences — and so does premature or inaccurate diagnosis. Both errors matter, and avoiding both requires the kind of careful, unhurried clinical evaluation that is central to how we practice at Wave.
The diagnostic challenge — in both directions
Few conditions in outpatient psychiatry generate more diagnostic error than bipolar disorder — and crucially, that error runs in both directions. Bipolar disorder is missed when it is present. It is also diagnosed when something else is actually going on. Both mistakes carry serious clinical consequences, and understanding both is essential to appreciating why an accurate initial evaluation matters so much.
Missing bipolar disorder — the underdiagnosis problem
Patients with bipolar disorder are overwhelmingly more likely to be initially misdiagnosed with unipolar major depression than with any other condition. This happens because depressive episodes are the predominant mood state across the bipolar spectrum, because patients presenting for psychiatric care are far more likely to be in a depressive episode than a manic or hypomanic one, and because hypomanic episodes in particular are frequently ego-syntonic — experienced as periods of high functioning, creativity, and productivity rather than illness — and are therefore not spontaneously reported and not systematically asked about.
The consequences of missing a bipolar diagnosis and treating as unipolar depression are clinically significant. Antidepressant monotherapy in bipolar disorder can precipitate manic or hypomanic episodes, accelerate mood cycling, induce mixed states, and increase long-term instability. Many patients who have cycled through multiple antidepressants without adequate response, or who have experienced destabilization on antidepressants, are carrying an unrecognized bipolar diagnosis that reframes their entire treatment history.
Accurate diagnosis requires a clinical interview that explicitly and systematically explores the full range of mood states across the patient's lifetime — not just the presenting depressive episode. It requires asking about periods of elevated mood, decreased need for sleep, increased goal-directed activity, impulsive or reckless behavior, grandiosity, and pressured speech. It requires taking a careful family history, reviewing the illness course, and understanding how the patient has responded to prior treatments.
Overdiagnosis of bipolar disorder — the equally important problem
The flip side of this diagnostic picture is less frequently discussed but equally consequential. Bipolar disorder is also regularly overdiagnosed — applied to patients whose mood instability, emotional reactivity, and interpersonal difficulties are better explained by other conditions entirely.
Borderline personality disorder is perhaps the most commonly misidentified as bipolar disorder. Both conditions involve significant emotional dysregulation, impulsivity, and mood instability — but the nature of that instability differs in clinically important ways. In borderline personality disorder, mood shifts tend to be rapid and reactive — triggered by interpersonal events, fears of abandonment, or perceived rejection — and typically resolve within hours. They are fundamentally tied to the relational and psychological dynamics of the person's life. In bipolar disorder, mood episodes are more sustained, more autonomous from external triggers, and more clearly episodic against a background of relative stability. Misdiagnosing borderline personality disorder as bipolar disorder leads to treatment with mood stabilizers and antipsychotics that may provide limited benefit while leaving the underlying psychological and relational difficulties entirely unaddressed — often for years.
PTSD and complex trauma are another frequent source of misdiagnosis. Trauma produces hyperarousal, emotional dysregulation, sleep disruption, impulsivity, dissociation, and rapidly shifting mood states that can strongly resemble bipolar disorder — particularly when the trauma history is not elicited carefully or not recognized as clinically central. A patient with complex PTSD presenting with emotional lability, hypervigilance, sleep disruption, and difficulty regulating affect may receive a bipolar diagnosis when what they are actually carrying is the legacy of traumatic experience that has never been adequately treated. The treatment implications are entirely different.
ADHD in adults generates significant diagnostic confusion with bipolar disorder — particularly bipolar II — because of the overlapping features of distractibility, impulsivity, emotional dysregulation, and variable functioning. Distinguishing between them requires careful attention to the developmental history, the episodic versus chronic nature of the symptoms, and the specific character of the mood and attention difficulties.
Substance use disorders can produce mood cycling, impulsivity, grandiosity, decreased need for sleep, and depressive episodes that closely mimic the full bipolar picture — and the co-occurrence of genuine bipolar disorder and substance use is common enough to complicate the differential further. Establishing a clear timeline of symptoms in relation to substance use is essential and sometimes requires a period of sustained sobriety before a reliable diagnosis can be made.
Medical conditions — including thyroid disorders, autoimmune conditions, neurological illness, and certain medications — can produce mood instability that mimics bipolar disorder and must be considered in every differential.
What this means in practice
Getting the bipolar diagnosis right — in either direction — requires clinical experience, a thorough and unhurried initial evaluation, and a genuine commitment to following the evidence rather than pattern-matching to a familiar diagnosis. Our psychiatrists approach this diagnostic question with the seriousness it deserves. We do not apply the bipolar label because a patient has mood swings. We do not withhold it because their episodes have never required hospitalization. We take the time to understand the full longitudinal picture before arriving at a formulation — and we are transparent with patients about what is certain, what is probable, and what requires more time to clarify.
Bipolar I and bipolar II — an important distinction
Bipolar I disorder is defined by the presence of at least one full manic episode — a distinct period of abnormally elevated or irritable mood and increased energy lasting at least seven days, or of any duration if hospitalization is required, that is sufficiently severe to cause marked functional impairment or require hospitalization. Depressive episodes occur in the vast majority of patients with bipolar I but are not required for the diagnosis.
Bipolar II disorder is defined by the presence of at least one hypomanic episode and at least one major depressive episode, in the absence of a full manic episode. Hypomania is a less severe form of elevated mood — noticeable to others and representing a change from baseline, but not causing the marked functional impairment or psychotic features that characterize mania. Bipolar II is not a milder version of bipolar I — it carries its own significant burden of illness, dominated by the depressive pole, and requires its own specific pharmacological approach.
This distinction matters clinically because the treatment approaches for bipolar I and bipolar II differ in important ways — including the evidence base for specific mood stabilizers, the approach to antidepressant use, and the long-term management strategy. Our psychiatrists make this distinction carefully and treat each presentation accordingly.
Our approach to bipolar disorder treatment
Treatment of bipolar disorder at Wave is long-term, individualized, and built around three core goals: stabilizing the current episode, preventing future episodes, and supporting the patient's functioning and quality of life across the full arc of the illness. We do not approach bipolar disorder as a condition to be managed with a single medication and quarterly check-ins. It is a complex, lifelong condition that requires ongoing clinical engagement, careful monitoring, and a treatment relationship built on genuine knowledge of the patient over time.
Mood stabilization and pharmacotherapy
Pharmacotherapy is the cornerstone of bipolar disorder treatment, and the evidence base for mood stabilizing medications is well-established. Lithium remains the most robustly evidence-based mood stabilizer available — with demonstrated efficacy for mania, bipolar depression, and long-term relapse prevention, as well as meaningful evidence for suicide risk reduction that no other mood stabilizer replicates. Valproate, lamotrigine, and several atypical antipsychotics have significant evidence bases for specific phases of bipolar disorder and are used at Wave when clinically indicated.
Medication selection in bipolar disorder is nuanced and highly individualized — accounting for the specific type of bipolar disorder, the predominant pole of illness, the history of prior medication trials and responses, comorbid conditions, side effect considerations, and the patient's own priorities and preferences. Our psychiatrists approach this complexity with the depth of psychopharmacological knowledge it requires.
The role of antidepressants in bipolar disorder requires specific comment. Antidepressant monotherapy is contraindicated in bipolar disorder, and the evidence for antidepressants as adjunctive agents — even when combined with mood stabilizers — is considerably more limited and contested than is generally appreciated. Our psychiatrists are conservative in their use of antidepressants in the bipolar population and are direct with patients about the evidence and the risks.
Psychotherapy
Psychotherapy is an important adjunct to pharmacotherapy in bipolar disorder and has a meaningful evidence base for reducing relapse rates, improving medication adherence, and enhancing functional recovery.
Psychoeducation — a structured approach to helping patients and their families understand the nature of bipolar disorder, recognize early warning signs of mood episodes, and develop a personalized relapse prevention plan — is among the most well-validated psychosocial interventions for bipolar disorder and is incorporated into treatment at Wave from the earliest stages of care.
Interpersonal and Social Rhythm Therapy, which addresses the role of regular sleep-wake cycles, meal times, and daily routines in mood regulation, has evidence specifically in bipolar populations and informs how our psychiatrists discuss lifestyle and daily structure with patients.
CBT and psychodynamic approaches address the cognitive patterns, relational difficulties, and psychological dimensions of living with a chronic mood disorder — including the grief of diagnosis, the impact of past episodes on self-concept and relationships, and the ongoing challenge of building a life that accommodates the demands of the illness without being defined by it.
Longitudinal monitoring and relapse prevention
One of the most important aspects of bipolar disorder management is what happens between episodes — the ongoing monitoring that allows early identification of prodromal symptoms, the gradual mood shifts and behavioral changes that precede a full episode and that, when caught early, can often be addressed before they escalate. Our psychiatrists discuss individualized early warning signs and relapse prevention strategies with every bipolar patient, and remain accessible between scheduled appointments through our Spruce Health platform for clinical concerns that arise between visits.
Sleep is a particularly critical monitoring target in bipolar disorder. Decreased need for sleep — not insomnia, but a genuine reduction in the amount of sleep required — is one of the earliest and most reliable prodromal signs of hypomania or mania. Our psychiatrists educate patients about this specifically and establish clear protocols for what to do when it occurs.
Bipolar disorder rarely presents without comorbid conditions. Anxiety disorders co-occur with bipolar disorder at high rates and significantly complicate both diagnosis and treatment. Substance use disorders are substantially more prevalent in bipolar populations than in the general population and interact with mood instability in ways that make both conditions harder to treat. ADHD co-occurs with bipolar disorder with meaningful frequency and presents significant diagnostic challenges given their overlapping features.
Personality disorders — particularly borderline personality disorder — co-occur with bipolar disorder genuinely in some patients, while in others the personality diagnosis better accounts for the full picture without a concurrent bipolar diagnosis. Distinguishing comorbidity from misdiagnosis is one of the most clinically demanding tasks in this population and one that requires careful, longitudinal assessment rather than a single cross-sectional evaluation.
Our psychiatrists assess for and address comorbid conditions as a routine component of bipolar disorder treatment, with explicit attention to the diagnostic questions that comorbidity raises rather than simply adding diagnoses to a list.
Bipolar disorder and comorbidity
Bipolar disorder and suicide risk
Bipolar disorder carries one of the highest suicide risks of any psychiatric condition — with lifetime rates of suicidal behavior substantially higher than in the general population, and a particular concentration of risk during depressive and mixed episodes. This is a clinical reality that our psychiatrists address directly and without euphemism.
Lithium has the strongest evidence base of any psychiatric medication for suicide risk reduction in bipolar disorder — an effect that appears to be independent of its mood stabilizing properties — and this evidence is a meaningful factor in medication selection discussions with patients who carry elevated risk. Our psychiatrists assess suicide risk as a routine component of every clinical encounter with bipolar patients and maintain the kind of longitudinal clinical relationship that allows meaningful monitoring of risk over time.
Living with bipolar disorder
Bipolar disorder is a lifelong condition — and living well with it requires more than medication compliance and regular appointments. It requires a genuine understanding of the illness and how it manifests individually, a set of practical tools for recognizing and responding to mood shifts early, a lifestyle structure that supports mood stability, and a clinical relationship built on honest, ongoing communication.
Our psychiatrists approach bipolar disorder with the long-term perspective it requires. We are interested not just in the management of acute episodes but in the full arc of a patient's life — their relationships, their work, their goals, and the ways in which living with a mood disorder intersects with all of these. We are direct about what the evidence supports and what it does not, honest about prognosis and the realistic expectations that follow from it, and committed to helping patients build lives of genuine quality and meaning alongside the demands of this condition.
Insurance and fees
Wave Psychiatric Group accepts Aetna, Optum / UnitedHealthcare Behavioral Health, Meritain Health, Oxford Health Plans, ComPsych, UC SHIP, and others for diagnostic assessment appointments. Self-pay rates are also available.
Call us at 323-688-6380 or complete our intake form and our team will verify your benefits before your first appointment.
Frequently Asked Questions
How do I know if I have bipolar disorder or depression?
This is one of the most important diagnostic questions in outpatient psychiatry, and it is not always answerable in a single appointment. The key clinical distinction lies in the history — specifically, whether you have ever experienced periods of elevated, expansive, or irritable mood with increased energy and decreased need for sleep that represent a clear change from your baseline. These periods are frequently not experienced as illness and are therefore not spontaneously reported. A thorough psychiatric evaluation that explicitly explores the full range of mood states across your lifetime is the essential starting point. If you have been treated for depression and have not responded well, or have been destabilized on antidepressants, a careful reassessment for bipolar disorder is warranted.
How is bipolar disorder different from borderline personality disorder?
This is one of the most clinically important differential diagnoses in outpatient psychiatry — and one of the most frequently confused. Both conditions involve emotional dysregulation, impulsivity, and mood instability, but the nature of that instability differs meaningfully. In borderline personality disorder, mood shifts tend to be rapid, reactive, and tied to interpersonal triggers — particularly fears of abandonment or perceived rejection — and typically resolve within hours. In bipolar disorder, mood episodes are more sustained, more episodic, and more autonomous from external events. A thorough evaluation that explores the character, timing, and triggers of mood shifts — alongside the full developmental and relational history — is essential to making this distinction accurately.
Could my mood symptoms be caused by trauma rather than bipolar disorder?
Yes — and this is a clinically important question that is frequently not asked carefully enough. PTSD and complex trauma produce hyperarousal, emotional dysregulation, sleep disruption, and rapidly shifting mood states that can strongly resemble bipolar disorder. A thorough trauma history is an essential component of every bipolar disorder evaluation at Wave. In some patients, what has been labeled bipolar disorder is more accurately understood as the psychiatric sequelae of unprocessed traumatic experience — a distinction with profound treatment implications.
Is bipolar disorder genetic?
Bipolar disorder has a substantial heritable component — among the highest of any psychiatric condition, with twin studies suggesting heritability estimates in the range of 60 to 80 percent. Having a first-degree relative with bipolar disorder meaningfully elevates your risk. However, genetic vulnerability is not destiny — environmental factors, early experiences, and the complex interaction between genes and context all shape whether and how the condition manifests. Family history is an important piece of the diagnostic picture and is taken carefully at every initial evaluation.
Can bipolar disorder be managed without medication?
For the vast majority of patients with bipolar I or II disorder, medication is an essential component of long-term management. The evidence for mood stabilizing medications in preventing relapse, reducing episode severity, and lowering suicide risk is robust, and the risks of untreated or undertreated bipolar disorder are real. Psychotherapy and lifestyle interventions are important adjuncts that meaningfully improve outcomes, but they do not replace pharmacotherapy in most cases. Our psychiatrists are direct about this with patients while remaining attentive to individual preferences and concerns about medication.
What is a mixed episode?
A mixed episode — described in current diagnostic criteria as a mixed features specifier — refers to a mood state in which features of both mania or hypomania and depression are simultaneously present. Mixed states are clinically important because they carry an elevated suicide risk relative to either pure mania or pure depression, and because they can be difficult to recognize. The combination of depressive affect with manic energy and impulsivity is particularly dangerous. Mixed states also respond differently to treatment than pure mood episodes, and recognizing them accurately shapes the pharmacological approach.
Is bipolar II disorder less serious than bipolar I?
Bipolar II is not a milder version of bipolar I. While the manic episodes of bipolar I can be dramatically disruptive and dangerous, bipolar II carries its own significant burden — dominated by the depressive pole, with depressive episodes that are often severe, frequent, and treatment-challenging. Functional impairment in bipolar II is substantial, and the condition is associated with its own elevated suicide risk. The absence of full mania does not diminish the seriousness of bipolar II disorder or the importance of accurate diagnosis and adequate treatment.